Medicare can pay for obesity drugs like Wegovy in certain heart patients
Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday.
The Centers for Medicare & Medicaid Services issued new guidance that says Medicare Part D drug benefit plans — which are offered through private insurers — could cover anti-obesity drugs that are approved for an additional use.
The move could pave the way for thousands of new prescriptions, resulting in billions of dollars in increased spending, analysts have said.
In practice, the guidance opens the door to wider coverage of Wegovy, the brand name of Novo Nordisk’s obesity medication semaglutide. The U.S. Food and Drug Administration this month approved a label change that allows Wegovy to be used to reduce the risk of cardiovascular events in people who are overweight or have obesity and also have existing heart disease.
Related articles
Adams, Reyna, Turner, Ream are US concerns ahead of Copa America
NEW YORK (AP) — Tyler Adams, Gio Reyna, Matt Turner and Tim Ream will be given the three weeks ahead2024-05-21Adames homers twice with 4 RBIs, Brewers beat Rays 7
MILWAUKEE (AP) — Willy Adames homered twice with four RBIs and Colin Rea pitched six scoreless innin2024-05-21A new Statehouse and related projects will cost about $400 million
MONTGOMERY, Ala. (AP) — The construction of a new Alabama Statehouse, now underway in Montgomery, an2024-05-21Biden administration weighing measures to help Palestinians bring family from region
WASHINGTON (AP) — The Biden administration is weighing measures to help Palestinians living in the U2024-05-21Analysis: Larson enters conversation with Verstappen as best drivers in the world
INDIANAPOLIS (AP) — Ask almost any hardcore motorsports fan who the best driver in the world is righ2024-05-21Ben Stiller feuds with NBA player
Die-hard Knicks fan Ben Stiller didn't mince his words when he called out NBA player-turned-analyst2024-05-21
atest comment